Van Andel Institute’s Hui Shen, Ph.D., has been elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows, a prestigious appointment that represents the top 2% of medical and biological engineers.
Brian Brown, PhD, Director of the Icahn Genomics Institute at the Icahn School of Medicine at Mount Sinai, has been elected to the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE).
By analyzing DNA and proteins in the blood of people with and without acute spinal cord injuries (SCIs), researchers at the Johns Hopkins University School of Medicine have developed a novel blood test that has the potential to rapidly predict severity and likelihood of sensory and motor recovery within six months in a cost-effective manner.
Scientists have unveiled a revolutionary method for mass-producing high-quality human mitochondria, potentially transforming treatments for degenerative diseases. By refining stem cell culture conditions, researchers achieved an extraordinary 854-fold increase in mitochondrial production while significantly enhancing energy output.
A study led by Johns Hopkins Medicine researchers could advance the development of new drugs that block or open such signaling channels to treat conditions as varied as epilepsy and some intellectual disorders.
FAMU-FSU College of Engineering researchers have created a new method for studying protein degradation within immune cells that uses engineered microparticles to track and analyze degradation processes more effectively than traditional methods. The work, which was published in ACS Applied Materials & Interfaces, has important implications for treating diseases such as cancer, Alzheimer’s disease and autoimmune disorders.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
This study achieved CRISPR/Cas9-mediated genome editing in grass carp (Ctenopharyngodon idella), China's most economically vital freshwater fish. Targeting the tyrb gene critical for pigmentation were performed. Mutations confirmed by sequencing caused a golden phenotype with melanophore reduction. Using multiple gRNAs enhanced mutation rates (88.9%) and triggered large DNA deletions.
Engenheiros de manufatura estão na vanguarda de trazer novos medicamentos derivados de fontes humanas, como células, sangue e genes, para os pacientes. Eles produzem o que muitas vezes são bioterapias pioneiras do seu tipo para doenças que anteriormente tinham poucas ou nenhuma opção de tratamento.
Manufacturing engineers are at the forefront of bringing new medicines derived from human sources such as cells, blood and genes to patients. They produce what are often first-of-their kind biotherapies for diseases that previously had few or no treatment options.
JACKSONVILLE, Florida — Ingenieros de manufactura están a la vanguardia de llevar nuevos medicamentos derivados de fuentes humanas, como células, sangre y genes, a los pacientes. Ellos producen lo que a menudo son bioterapias pioneras de su tipo para enfermedades que anteriormente tenían pocas o ninguna opción de tratamiento.
Scientists have been given a £1.1m grant by the UKRI Medical Research Council (MRC) to continue their life-changing research, after identifying a new disease which causes some children’s brains to develop abnormally.
CDI Labs Canada Inc., a leading provider of services for proteome-wide antibody profiling and target identification, today announced the launch of its Technology Access Program for custom peptide libraries for serum antibody analysis services. These services utilize phage display immunoprecipitation sequencing (PhIP-Seq), a powerful method of multiplexed analysis that combines next-generation proteomics with high-throughput DNA sequencing, to provide researchers with unparalleled insights into the intricate connection between antibodies and diseases.
جاكسونفيل، ولاية فلوريدا — يحتل مهندسو التصنيع الصدارة في جلب الأدوية الجديدة المشتقة من مصادر بشرية، مثل الخلايا والدم والجينات، للمرضى. وينتجون علاجات حيوية غالبًا ما تكون الأولى من نوعها لأمراض لم يكن لها في السابق سوى خيارات علاجية محدودة أو لم يكن لها أي خيارات.
Mukhilan Saravanakumar found a way to mix two passions – music and science – into a harmonious college experience at Rutgers University-New Brunswick. The sophomore, a member of the honors program at the School of Environmental and Biological Sciences, is pursuing a major in biotechnology and a double minor in data science and music.